Medical Properties Trust 株価情報 (NYSE: MPW)

最新ニュース Medical Properties Trust (NYSE:MPW) 株価情報

Medical Properties Trust

Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. The group's geographic areas are the United States, the United Kingdom, and All other countries.

Medical Properties Trust, Inc. common stock

Medical Properties Trust Inc

Monolithic Power Systems, Inc. - Common Stock

Monolithic Power Systems Inc

Dividend stocks are gaining attention as investors crave certainty and downsize protection following market volatility triggered by President Donald Trump's tariff announcement on April 2. Dividend stocks have proven their resilience in the past. The S&amp;P 500 High Dividend Index outperformed the S&amp;P 500 in the dot-com bubble and COVID-19 market crash, according to an <a href="https://www.spglobal.com/spdji/en/documents/education/education-the-importance-of-dividends.pdf">S&amp;P Global</a> research report.
Earlier this month, a dividend investor <a href="https://www.reddit.com/r/dividends/comments/1jqucki/account_update_6000month/">shared</a> his portfolio and income details on r/Dividends — a Reddit discussion board with over 700,000 followers. The portfolio screenshots shared by the investor on the social platform showed his monthly dividend income stood at $6,027.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
The investor said he had been waiting to buy stocks on a pullback, and his chance finally came following the recent market selloff.
"What a bloody day today but it did hit the price target I have been waiting for. Now that I reached $6,000, now I am going to use this money to start buying more VOO and discounted tech stocks like Google, Amazon Microsoft, Broadcom, etc."
The investor said dividend investing is not a "get rich quick" scheme and it took him 20 years to reach this income milestone. He urged investors to "keep grinding until we don't have to."
"As long as you are consistent with your investment, you will also get there," he added.
Trending: It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
The investor's portfolio had a total worth of about $1.1 million. Let's take a look at some of his biggest holdings.
Enterprise Products Partners
Number of Shares: 5,357
Enterprise Products Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>) was the biggest holding of the investor, accounting for about 16% of his total portfolio. He had 5,357 shares of the energy company, according to the portfolio screenshots he shared on Reddit. The stock has a dividend yield of over 7%.
JPMorgan Equity Premium Income ETF&nbsp;
Number of Shares: 2,648
The Redditor earning $6,000 a month in dividends had a $146,000 stake in JPMorgan Equity Premium Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEPI#NYSE">JEPI</a>). The fund invests in some of the most notable large-cap U.S. stocks and generates income by selling call options.&nbsp; Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), Southern Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SO#NYSE">SO</a>) and Progressive Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) are among the fund's top holdings.
Ares Capital
Number of Shares: 2,501
Ares Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCC#NASDAQ">ARCC</a>) a business development company, was one of the top stocks in the investor&#8217;s portfolio. The stock has a dividend yield of over 9%.
Blackstone Secured Lending
Number of Shares: 2,501
Blackstone Secured Lending (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXSL#NYSE">BXSL</a>) is a business development company mainly investing in private U.S. companies&#8217; first-lien senior secured debt. The company has a dividend yield of about 11%. The stock is down 14% so far this year.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
Realty Income
Number of Shares: 850
Realty Income (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>) is one of the most popular monthly dividend stocks among Redditors. The REIT has a dividend yield of 5.8%. Last month, Realty Income raised its dividend by 0.2%.&nbsp;
Medical Properties
Number of Shares: 6,769
Medical Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) is an Alabama-based REIT focused on hospital facilities. It has a dividend yield of about 6%. The investor had 6,769 shares of the company in his portfolio. The stock is up 32% over the past year.
Enbridge
Number of Shares: 761
Canadian energy infrastructure company Enbridge Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENB#NYSE">ENB</a>) has a dividend yield of 6.2%. The company has consistently <a href="https://www.enbridge.com/media-center/news/details?id=123836&amp;lang=en">raised</a> its dividends for about three decades now.
JPMorgan Nasdaq Equity Premium Income ETF
Number of Shares: 662
The investor had 662 JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JEPQ#NASDAQ">JEPQ</a>) shares in his portfolio. JEPQ is a high-yield covered call ETF that distributes monthly dividend income. The ETF invests in Nasdaq companies and generates extra income by selling call options. It yields about 10%.
Read Next:
<ul>
<li>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>

Personal Finance

ARCC

BXSL

JEPI

JEPQ

Dividend Investor Making $6,000/Month Shares Portfolio; Bought More on Recent 'Bloody Day' Selloff — 'Keep Grinding Until We Don't Have To'

Medical Properties Trust's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) short percent of float has fallen 4.09% since its last report. The company recently reported that it has 176.85 million shares sold short, which is 40.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 13.38 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Medical Properties Trust Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743181226_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Medical Properties Trust has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Medical Properties Trust's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Medical Properties Trust's peer group average for short interest as a percentage of float is 4.65%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

What Does the Market Think About Medical Properties Trust?

Investing in dividend-paying stocks has long been a popular investment strategy for those seeking to generate <a href="https://www.benzinga.com/markets/25/03/44244110/how-this-59-year-old-investor-built-a-real-estate-portfolio-that-generates-105kper-month-in-passive">passive income</a> and build long-term wealth.
A well-constructed portfolio provides a cash flow stream and the potential for capital appreciation over time for the investor, so many are seeking advice online on this matter. For many individuals, <a href="https://www.benzinga.com/markets/25/01/43372321/im-39-and-built-900k-in-7-years-dividend-investor-eyes-retirement-by-55-with-explosive-income-shares">dividend</a> investments are charming because of their ability to compound returns, especially when reinvested. Yet, building a portfolio to reap these benefits requires discipline, patience, and a good strategy.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>
And this is what a Reddit user has done. The investor recently shared his success story in a community on the discussion board, revealing that he&#8217;s crossed the $12,895 per year in dividends milestone. This achievement, which took him nearly three years to accomplish, brings him an extra $1,000 per month in passive income.
&#8220;It took me almost three years to get to this point… I have the feeling it's gonna really start taking off from here! Pretty pumped!&#8221; the investor wrote.
The investor&#8217;s portfolio consists of over 18 stocks and funds, each contributing to the $12,895 annual dividend income. Let&#8217;s explore the poster&#8217;s top 10 favorite holdings below.
Trending: It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
<h2 class="wp-block-heading">$12,895/Year in Dividend Income: Top 10 Stocks and Funds That Contribute to This Sum</h2>
ZIM Integrated Shipping Services
Israeli shipping company ZIM Integrated Shipping Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) operates globally and has benefited from high freight rates. ZIM has an annual dividend yield of approximately 39.60%.
TORM Plc
Based in Denmark, TORM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMD#NASDAQ">TRMD</a>) is a container shipping company that transports refined oil products. Investors like TRMD because of its high dividend history and exposure to global oil transport. The company pays 36.66% in dividends.
Mesabi Trust
With an annual dividend yield of 25.84%, Mesabi Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSB#NYSE">MSB</a>) is a royalty trust that makes revenue from iron ore production in Minnesota, with distributions based on the mining company's earnings. Individuals invest in MSB because of the exposure to commodities it offers and the high dividends it pays.
Medical Properties Trust
A real estate investment trust, Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) pays investors 5.48% annually in dividends. MPW owns hospitals and leases them to operators, and has a history of strong dividend paying.
VOC Energy Trust
VOC Energy Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOC#NYSE">VOC</a>) is a royalty trust earning revenue from oil and gas production in Texas and Kansas. VOC pays investors approximately 22.71% in annual dividends and is sought especially during high oil prices.
See Also: Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a>
Amplify High Income ETF
Paying 12.58% in dividends, Amplify High Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YYY#NYSE">YYY</a>) is an ETF focused on high-income closed-end funds, offering diversified high-yield exposure.
Abrdn Income Credit Strategies Fund
Another closed-end fund, Abrdn Income Credit Strategies Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACP#NYSE">ACP</a>) invests in high-yield bonds and credit securities. ACP pays investors approximately 18.73% in dividends.
Vale S.A.
Vale&nbsp; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) is a Brazilian mining giant focused on iron ore, nickel, and copper, and one of the largest iron ore producers globally. VALE has an annual dividend yield of around 7.76%.
Verizon Communications
With a dividend yield of around 6.21%, Verizon Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) is a major U.S. telecom company providing wireless and broadband services. Investors like VZ because of its stable, defensive stock with a long history of dividend growth.
Aker BP ASA
Aker BP ASA is a Norwegian oil and gas company focusing on offshore production in the North Sea. Paying investors approximately 12.1% in annual dividends, AKRBF has solid payouts and growth potential.&nbsp;
Read Next:
<ul>
<li>Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a></li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>

TRMD

VALE

High-Yield Dividend Investor Making $12,900 Per Year Names 10 Favorite Stocks – 'Took Me Almost 3 Years To Get To This Point'

WIIM

Medical Properties Trust shares are trading higher after Exane BNP Paribas upgraded the stock from neutral to outperform and raised the price target from $5 to $9.

Medical Properties Trust shares are trading higher after Exane BNP Paribas upgraded the stock from neutral to outperform and raises the price target from $5 to $9.

Exane BNP Paribas analyst Nate Crossett upgrades Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) from Neutral to Outperform and raises the price target from $5 to $9.

News

Upgrades

Price Target

Analyst Ratings

Exane BNP Paribas Upgrades Medical Properties Trust to Outperform, Raises Price Target to $9

RBC Capital analyst Michael Carroll maintains Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) with a Sector Perform and raises the price target from $4 to $5.

RBC Capital Maintains Sector Perform on Medical Properties Trust, Raises Price Target to $5

Wells Fargo analyst Connor Siversky maintains Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) with a Underweight and raises the price target from $4 to $5.

Wells Fargo Maintains Underweight on Medical Properties Trust, Raises Price Target to $5

These eight mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Root, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) stock gained 34.89% after the company reported <a href="https://www.benzinga.com//node/43993814" target="_blank" rel="noreferrer noopener">better-than-expected Q4</a> financial results. Wells Fargo raised the price forecast on the stock <a href="https://www.benzinga.com/quote/ROOT/analyst-ratings" target="_blank" rel="noreferrer noopener">from $80 to $97</a>.</li>
<li>Bridge Investment Group Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRDG#NYSE">BRDG</a>) shares jumped 32.45% after the company entered a deal to be acquired by Apollo Global Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) in an all-stock <a href="https://www.benzinga.com//node/43917364" target="_blank" rel="noreferrer noopener">transaction valued at around $1.5 billion</a>. Analysts revised the <a href="https://www.benzinga.com/quote/brdg/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Huron Consulting Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HURN#NASDAQ">HURN</a>) shares rose 23.21% after the company reported better-than-<a href="https://www.benzinga.com//node/43956537" target="_blank" rel="noreferrer noopener">expected quarterly financial results</a>. Also, multiple firms raised their respective <a href="https://www.benzinga.com/quote/hurn/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) shares increased 21.15% after the company reported better-<a href="https://www.benzinga.com//node/44004172" target="_blank" rel="noreferrer noopener">than-expected financial results</a>.</li>
<li>ZoomInfo Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) stock escalated 20.83% after the company reported 2024 <a href="https://www.benzinga.com//node/43990629" target="_blank" rel="noreferrer noopener">fiscal-year fourth-quarter earnings</a>. Scotiabank analyst Allan Verkhovski maintained a Sector Perform rating and raised the price <a href="https://www.benzinga.com/quote/zi/analyst-ratings" target="_blank" rel="noreferrer noopener">forecast from $10.3 to $11</a>.</li>
<li>Lantheus Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>) stock rose 19.93% after it reported quarterly adjusted <a href="https://www.benzinga.com//node/43968835" target="_blank" rel="noreferrer noopener">EPS and sales above estimates</a>. Truist Securities analyst Richard Newitter maintained a Buy rating and raised the <a href="https://www.benzinga.com/quote/lnth/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast from $120 to $127</a>.</li>
<li>Alignment Healthcare, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) stock gained 19.04% after the company reported better-than-expected Q4 financial results and issued an FY25 outlook. Multiple analyst firms raised their respective <a href="https://www.benzinga.com/quote/ALHC/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecasts on the stock</a>.</li>
<li>VSE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEC#NASDAQ">VSEC</a>) stock jumped 18.49%  after the company reported better-than-<a href="https://www.benzinga.com//node/43990909" target="_blank" rel="noreferrer noopener">expected fourth-quarter results</a>.</li>
</ol>
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/44067124/xpeng-li-auto-and-anheuser-busch-inbev-are-among-top-11-large-cap-gainers-last-week-feb-24-feb-28-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Xpeng, Li Auto And Nutanix Are Among Top 12 Large-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?</a></li>
<li><a href="https://www.benzinga.com/news/large-cap/25/03/44067248/tesla-palantir-and-microstrategy-are-among-top-12-large-cap-losers-last-week-feb-24-feb-28-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Tesla, Palantir And MicroStrategy Are Among Top 12 Large-Cap Losers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?</a></li>
</ul>

Equities

Mid Cap

Movers

ALHC

BRDG

HURN

LNTH

ROOT

VSEC

Root And ZoomInfo Are Among Top 8 Mid-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?

Medical Properties Trust shares are trading higher after the company reported better-than-expected Q4 financial results.

Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.16 by 12.5 percent. This is a 50 percent decrease over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $231.84 million which beat the analyst consensus estimate of $217.57 million by 6.56 percent. This is a 31.13 percent decrease over sales of $336.62 million the same period last year.

Earnings

Medical Properties Trust Q4 FFO $0.18 Beats $0.16 Estimate, Sales $231.84M Beat $217.57M Estimate

AAON

ABCL

ACEL

ACHC

ACHR

ACIC

ACIW

ADSK

AIRG

ALEX

ALKT

ALTM

AMBP

AMPH

AMRC

AMWD

ARGX

ARLO

ARRY

ASTH

AUPH

AVPT

BBWI

BCSF

BECN

BLND

BWMX

CABO

CARS

CCOI

CDXS

CLCO

CLOV

CMBT

CMLS

CMPS

CODI

COLL

CRDF

CRNX

CRON

CSTL

CTKB

CUBE

CVEO

CYTK

DAIO

DCGO

DELL

DUOL

ECVT

EFXT

ERIE

Embraer-Empresa Brasileira De Aeronautica

ESEA

ESTC

EVRG

EXFY

FIGS

FOXF

FTDR

FWONA

FWONK

GBTG

GDEN

GDOT

GDRX

Earnings Scheduled For February 27, 2025

Reported Earlier, Medical Properties Trust Prices $1.5B 8.500% Senior Secured Notes And €1B 7.000% Senior Secured Notes, Both Maturing In 2032

Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) today announced that its operating partnership, MPT Operating Partnership, L.P. and MPT Finance Corporation, a wholly-owned subsidiary of the operating partnership (together, the "Issuers") have commenced a private offering of up to $2.0 billion in aggregate principal amount of its senior secured notes due 2032 and €500 million aggregate principal amount of its senior secured notes due 2032 (together, the "Notes"). The Issuers intend to use a portion of the net proceeds of the Notes to fund the redemption in full of the Issuers' 3.325% senior notes due 2025, 2.500% senior notes due 2026 and 5.250% senior notes due 2026, including related accrued interest, fees and expenses. The Issuers intend to use any remaining net proceeds for general corporate purposes, which may include repaying other indebtedness, including amounts outstanding from time-to-time under the Company's revolving credit facility, working capital, capital expenditures and potential future acquisitions.

Offerings

Medical Properties Trust Has Commenced A Private Offering Of Up To $2B In Aggregate Principal Amount Of Its Senior Secured Notes Due 2032 And €500 Million Aggregate Principal Amount Of Its Senior Secured Notes Due 2032

As of Jan. 27, 2025, three stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Terreno Realty Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRNO#NYSE">TRNO</a>)</h3>
<ul>
<li>On Jan. 17, Terreno Realty sold an industrial property located in South San Francisco, California on January 16, 2025 for a sale price of approximately $8.0 million. The company's stock surged around 10% over the past month and has a <a href="https://www.benzinga.com/quote/TRNO">52-week high of $71.63</a>.</li>
<li>RSI Value: 74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>TRNO Price Action: Shares of Terreno Realty gained 0.5% to close at $64.99 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Welltower Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>)</h3>
<ul>
<li>On Jan. 24, B of A Securities maintained a Buy rating on the stock and raised its price target from $190 to $221. The company's stock gained around 9% over the past month and <a href="https://www.benzinga.com/quote/WELL">has a 52-week high</a> of $140.75.</li>
<li>RSI Value: 72.9</li>
<li>WELL Price Action: Shares of Welltower gained 3.4% to close at $136.75 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Medical Properties Trust Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>)</h3>
<ul>
<li>On Dec. 19, 2024, Truist Securities analyst Michael Lewis maintained Medical Properties Trust with a Hold and lowered the price target from $6 to $4. The company's stock gained around 26% over the past month and has a <a href="https://www.benzinga.com/quote/MPW">52-week high</a> of $6.55.</li>
<li>RSI Value: 71.2</li>
<li>MPW Price Action: Shares of Medical Properties Trust gained 2.6% to close at $4.69 on Friday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43221604/att-nucor-and-3-stocks-to-watch-heading-into-monday">AT&amp;T, Nucor And 3 Stocks To Watch Heading Into Monday</a></li>
</ul>

Pre-Market Outlook

Markets

TRNO

WELL

Top 3 Real Estate Stocks That May Plunge In Q1

Reported Earlier, Medical Properties Trust Supports Prospect's Chapter 11 Sale Plans For Connecticut Hospitals

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.
<h3 class="wp-block-heading">Medical Properties Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>)</h3>
<ul>
<li>Dividend Yield: 8.54%</li>
<li>Truist Securities analyst Michael Lewis maintained a Hold rating and cut the price target from $6 to $4 on Dec. 19, 2024. This analyst has an accuracy rate of 69%.</li>
<li>RBC Capital analyst Michael Carroll downgraded the stock from Outperform to Sector Perform with a price target of $5 on May 14, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On Nov.7, Medical Properties Trust reported worse-than-expected third-quarter financial results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1">latest MPW news.</a> </li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/8356f98b-748a-4a66-8e7b-6e4f0dc6db31" alt="" style="width:606px;height:auto" /></a></figure>
<h3 class="wp-block-heading">EPR Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPR#NYSE">EPR</a>)</h3>
<ul>
<li>Dividend Yield: 7.74%</li>
<li>JP Morgan analyst Anthony Paolone maintained an Overweight rating and raised the price target from $48 to $51 on Sept. 9, 2024. This analyst has an accuracy rate of 64%.</li>
<li>Truist Securities analyst Ki Bin Kim maintained a Hold rating and boosted the price target from $44 to $46 on Aug. 16, 2024. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On Oct. 30, EPR Props posted better-than-expected quarterly results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1">latest EPR new</a>s.</li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/25fde8ab-3a45-4b71-980a-0efe0c0d9950" alt="" style="width:631px;height:auto" /></a></figure>
<h3 class="wp-block-heading">Omega Healthcare Investors, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OHI#NYSE">OHI</a>)</h3>
<ul>
<li>Dividend Yield: 7.39%</li>
<li>RBC Capital analyst Michael Carroll maintained a Sector Perform rating and raised the price target from $39 to $43 on Nov. 11, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Wells Fargo analyst Connor Siversky assumed an Overweight rating and increased the price target from $40 to $43 on Oct. 1, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Recent News: On Jan. 6, Omega Healthcare Investors named Matthew Gourmand as President.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1">OHI news</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="893" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10133010/image-64.png" alt="" class="wp-image-728777" style="width:563px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10133010/image-64.png 893w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10133010/image-64-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10133010/image-64-768x711.png 768w" sizes="(max-width: 893px) 100vw, 893px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42917071/top-2-health-care-stocks-that-are-ticking-portfolio-bombs-2">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

Dividends

Wall Street's Most Accurate Analysts Weigh In On 3 Real Estate Stocks With Over 7% Dividend Yields

Truist Securities analyst Michael Lewis maintains Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) with a Hold and lowers the price target from $6 to $4.

Truist Securities Maintains Hold on Medical Properties Trust, Lowers Price Target to $4

Legal

Medical Properties Trust Reaches Agreement With Viceroy Research And Its Members To Mutually Settle And Dismiss Defamation Lawsuit Filed In 2023; Terms Confidential

Mizuho analyst Vikram Malhotra maintains Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) with a Neutral and lowers the price target from $6 to $5.

Mizuho Maintains Neutral on Medical Properties Trust, Lowers Price Target to $5

Press Releases

Medical Properties Trust, Inc. Reports Third Quarter Results

Medical Properties Trust Announces Prospect's Binding Agreement to Sell Managed Care Business to Astrana Health

Medical Properties Trust Declares Regular Quarterly Dividend

Medical Properties Trust Announces Settlement with Viceroy Research

Medical Properties Trust Comments on Prospect Restructuring

Medical Properties Trust Announces Private Offering of Senior Secured Notes

Medical Properties Trust Announces Pricing of $1.5 Billion 8.500% Senior Secured Notes Due 2032 and €1.0 Billion 7.000% Senior Secured Notes Due 2032

Medical Properties Trust, Inc. Announces Fourth Quarter 2024 Financial Results Conference Call and Webcast

Comments

Medical Properties Trust

ニュース

最新ニュース Medical Properties Trust (NYSE:MPW) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル